In a recent article in the WSJ, Dr. Scott Gottlieb, former head of FDA, described the landscape of potential treatments and preventative measures currently under development.  The subtitle of the article was “Antivirals and antibody therapies are showing promise.  The FDA needs to pick up its pace.”  The article was advocating for moving the clinical…

Read More